Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long ‐term, multicenter phase 3 study of desmopressin in Japanese patients
ConclusionsDesmopressin ODTs (25 and 50 μg) demonstrated long‐term efficacy, improved QoL, and were well tolerated in Japanese male and female patients with nocturia treated for up to 1 year. Clinically meaningful improvements in patients’ QoL, assessed by N‐QoL, sleep quality, and bother, occur later than objective symptom im provements, such as voids.
Source: LUTS: Lower Urinary Tract Symptoms - Category: Urology & Nephrology Authors: Kristian V. Juul,
Fredrik L. Andersson,
Osamu Yamaguchi Tags: ORIGINAL ARTICLE Source Type: research
More News: Bed Wetting | Enuresis | Insomnia | Japan Health | Sleep Disorders | Sleep Medicine | Study | Urology & Nephrology